Demant Building Momentum Toward Market Share Gains in 2026
Demant is a Danish healthcare group focused on hearing aids. It operates as a vertically integrated business across three divisions: hearing aids, hearing care, and diagnostics.
Demant AS DEMANT
Bulls Say, Bears Say
Bulls
Demant’s strong product pipeline, led by the global rollout of Oticon Zeal in 2026, will likely result in above-market growth in the next few years.
Bears
Demant has underperformed Sonova over the last two years in hearing aids. Sonova was first to introduce real-time AI implementation, taking share from Demant.
News
Trading Information
- Previous Close Price
- DKK 314.20
- Day Range
- DKK 311.00–316.20
- 52-Week Range
- DKK 175.00–321.20
- Bid/Ask
- DKK 313.00 / DKK 313.20
- Shares Outstanding
- 210.90M
- Market Cap
- DKK 66.22B
- Volume/Avg
- 234,706 / 288,987
Key Statistics
- Price/Earnings (Normalized)
- 25.70
- Price/Sales
- 2.69
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 26,616
- Website
- https://www.demant.com
Competitors
Valuation
|
Metric
|
DEMANT
|
GN
|
SOON
|
|---|---|---|---|
Price/Earnings (Normalized) | 25.70 | 156.35 | 24.96 |
Price/Book Value | 5.89 | 1.54 | 5.69 |
Price/Sales | 2.69 | 1.23 | 4.14 |
Price/Cash Flow | 15.51 | 6.88 | 19.32 |
Price/Earnings
DEMANT
GN
SOON
Financial Strength
|
Metric
|
DEMANT
|
GN
|
SOON
|
|---|---|---|---|
Quick Ratio | 0.54 | 0.38 | 1.17 |
Current Ratio | 0.82 | 1.93 | 1.75 |
Interest Coverage | 6.70 | 0.18 | 23.14 |
Quick Ratio
DEMANT
GN
SOON
Profitability
|
Metric
|
DEMANT
|
GN
|
SOON
|
|---|---|---|---|
Return on Assets (Normalized) | 6.76% | −0.53% | 11.07% |
Return on Equity (Normalized) | 24.80% | −1.48% | 24.50% |
Return on Invested Capital (Normalized) | 9.75% | 0.50% | 16.97% |
Return on Assets
DEMANT
GN
SOON
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|N?<B<%b | LOCK|dbjQ | $167B | |||
| Medtronic PLC
MDT
| LOCK|<@?>$t | LOCK|%xvx | $111B | |||
| Stryker Corp
SYK
| LOCK|<!qbh!p@ | LOCK|>t$ | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|Gr&&>y# | LOCK|ZcPF | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|DMG!<f$ | LOCK|?C>>N | $49B | |||
| DexCom Inc
DXCM
| LOCK|!v><VGf | LOCK|$d!M^ | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|>h%YlxJ | LOCK|y&& | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|?h | LOCK|Zxz | $23B | |||
| Steris PLC
STE
| LOCK|clB>&^& | LOCK|!S?Q | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|F#%s!X# | LOCK|$P$ | $17B |
United States